Baopharma

BaoPharma is a biopharmaceutical company with GMP-compliant manufacturing facility. We engage in the research and production of recombinant enzyme and protein drugs, including recombinant human hyaluronidase PH20 (rhPH20), recombinant chymotrypsin, both of them with API in inventory. And rhPH20 has successfully completed phase III clinical trials in 2022.